Overview
MORROW provides preventive healthcare through an integrated longevity platform that combines clinical diagnostics with lifestyle coaching. Its process starts with comprehensive health screenings to measure longevity-related biomarkers, then uses AI and data from wearables to generate a personalized plan delivered through doctor guidance, expert coaching, and continuous monitoring, with the MORROW app serving as a central hub for real-time feedback. It differentiates itself with an ecosystem that links medical oversight, AI-driven personalization, and ongoing monitoring across six pillars of lifestyle medicine, using its Singapore flagship as a blueprint for scalable growth. The company aims to expand to 10+ locations across Asia, Australasia, and the Middle East and targets annual revenues above US$230 million.
Work here?Claim your company
Simplify's take
What believers are saying
- MORROW is open now, with daily hours and bookings active in Singapore.
- MORROW Medical holds Singapore MOH licence L/25M0780/MDS/001/252, reducing launch risk.
- Job listings and Grand Park City Hall partnerships show active commercial momentum in 2026.
What critics are saying
- US$230 million revenue by 2031 depends on flawless utilization across 10-plus sites.
- MORROW Medical bills separately from MORROW, complicating customer understanding and cross-sell conversion.
- Longevity clinics like Clinique La Prairie and health clubs like Equinox crowd the same affluent buyer.
What makes MORROW & MORROW Medical unique
- MORROW combines MOH-licensed medical care, coaching, and recovery at 10 Coleman Street.
- Its app links wearables, screening results, appointments, and lifestyle tracking into one workflow.
- Allen Law funded US$156 million, giving MORROW rare capital for a new clinic brand.
Help us improve and share your feedback! Did you find this helpful?